Your search for ‘Smart & Biggar’ returned 2,497 results

The Federal Court of Appeal recently heard a constitutional challenge to the new Patented Medicines Regulations that came into force on July 1, 2022.

CADTH has provided an online questionnaire for stakeholders to provide feedback; the online consultation period will run through to February 25, 2022.

This appeal arose in the context of a February 15, 2017 decision of the Minister of Health and Social Services (the "Minister") to halt coverage of Janssen's REMICADE ...

In November 2019, we highlighted the key proposed amendments to Regulations made under the Ontario Drug Benefit Act (ODBA) and the Drug Interchangeability and...

Santé Canada et la Food and Drug Administration des États-Unis (la « FDA ») ont créé un programme visant à soutenir la mise en place d'un programme de Demande de partage d'informations (« DPI »)...

On October 20, 2022, Saskatchewan announced it is introducing a biosimilars initiative.

Both the applicants and the respondent have appealed the June 29, 2020 decision striking subsection 3(4) of the Regulations Amending the Patented Medicines Regulations...

As we reported last month, the Minister of Health launched a consultation on a proposed Ministerial Reliance Order that would permit Health Canada to complete the examination of certain parts...

On January 1, 2025, Canada will implement a patent term adjustment (PTA) system to account for unreasonable delays by the Canadian Intellectual Property Office (CIPO) in issuing a patent.

Melanie Szweras and Teresa MacLean write for Biotechnology Focus Magazine discussing how gene patent elgibility in Canada may soon be evaluated in light of a challenge brought by the Children's Hospital of Eastern Ontario.

In a recent interview with the World Trademark Review (WTR), Principal Christian Bolduc discusses Bill 96 and its Regulations, and the implications for those doing business in Québec. On June 1, 2022, the Québec...

The Competition Bureau has sent warning letters to operators of clothing donation bins in the Montréal area requiring them to make corrections to the information on their bins.

During a recent meeting, the Canadian Intellectual Property Office (CIPO) revealed plans for a significant reduction in the first examination of Canadian trademark applications not using the pre-approved list of goods...

In an interesting factual situation concerning the scope of moral rights, the Quebec Court of Appeal, in 91439 Canada ltée (Éditions de Mortagne) c. Robillard, 2022 QCCA 76...

Since the beginning of the pandemic, the Food and Drug Administration (FDA) has been at a rapid pace in evaluating COVID-19 related diagnostic tests, amongst which include those that utilize patented technologies.

As previously reported, the Federal Court (FC) dismissed Janssen's application for judicial review of the decision of the Office of Submissions and Intellectual Property (OSIP) refusing to list...

Seedling Life Science Ventures ("Seedlings") is the plaintiff in a patent infringement action against Pfizer relating to Patent No. 2,486,935 and auto injectors.

Philip Mendes da Costa is a co-author of a recent briefing paper released by the International Federation of Intellectual Property Attorneys (FICPI).